SCHEMBL4750901

SCHEMBL4750901

Clc1nc(Cl)c2ncn(CCC34CC5CC(CC(C5)C3)C4)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.41
YTHDC1 Q96MU7 5/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
CNR2 P34972 1/20 0.35
EPHX2 P34913 1/20 0.33
HDAC3 O15379 3/20 0.33
HDAC4 P56524 3/20 0.33
HDAC1 Q13547 3/20 0.33
HDAC7 Q8WUI4 3/20 0.33
HDAC2 Q92769 3/20 0.33
HDAC10 Q969S8 3/20 0.33
HDAC11 Q96DB2 3/20 0.33
HDAC8 Q9BY41 3/20 0.33
HDAC6 Q9UBN7 3/20 0.33
HDAC9 Q9UKV0 3/20 0.33
HDAC5 Q9UQL6 3/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748530 0.87 CYP11B1 (0.46) P2RX7YTHDC1LMNATP53CYP11B1
SCHEMBL4752076 0.83 FDPS (0.43) P2RX7CYP11B1CYP11B2HDAC6
SCHEMBL30332411 0.73 P2RX7 (0.49) P2RX7YTHDC1LMNATP53HDAC3
SCHEMBL5158596 0.73 P2RX7 (0.49) P2RX7YTHDC1LMNATP53HDAC3
SCHEMBL11961126 0.73 P2RX7 (0.52) P2RX7YTHDC1LMNATP53HDAC3
SCHEMBL31237508 0.72 P2RX7 (0.48) P2RX7YTHDC1LMNATP53HDAC3
SCHEMBL8464465 0.71 TK1 (0.51) P2RX7YTHDC1LMNATP53HDAC3
SCHEMBL30332108 0.71 YTHDC1 (0.60) P2RX7YTHDC1LMNATP53CNR2
SCHEMBL944935 0.70 P2RX7 (0.46) P2RX7YTHDC1CNR2HDAC3HDAC4
SCHEMBL5161283 0.70 HDAC1 (0.49) P2RX7YTHDC1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008131502-A2 ANTIVIRAL COMPOUNDS OF THE ADAMANTANE TYPE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2008-11-06 WO claimed
WO-2008131502-A2 ANTIVIRAL COMPOUNDS OF THE ADAMANTANE TYPE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2008-11-06 WO disclosed